Heron Therapeutics, Inc. announced resignation of David Szekeres as Executive Vice President, Chief Operating Officer of the Company, effective July 20, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.6 USD | -0.83% | -2.70% | +111.76% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+111.76% | 542M | |
+51.85% | 57.87B | |
+41.11% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Heron Therapeutics, Inc. Announces Resignation of David Szekeres as Executive Vice President, Chief Operating Officer of the Company